Stay updated with breaking news from Talis One. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Philadelphia, Pennsylvania--(Newsfile Corp. - February 16, 2024) - A securities fraud class action complaint has survived a motion to dismiss and ...
Talis Biomedical Co. (NASDAQ:TLIS – Get Free Report) saw a significant increase in short interest in October. As of October 31st, there was short interest totalling 17,100 shares, an increase of 19.6% from the October 15th total of 14,300 shares. Currently, 1.0% of the company’s stock are short sold. Based on an average trading volume […]
Talis Biomedical Co. (NASDAQ:TLIS – Get Free Report) saw a significant decline in short interest in September. As of September 30th, there was short interest totalling 11,500 shares, a decline of 25.8% from the September 15th total of 15,500 shares. Approximately 0.7% of the company’s stock are short sold. Based on an average trading volume […]
Talis Biomedical (NASDAQ:TLIS – Get Free Report) will be releasing its earnings data on Monday, July 31st. Talis Biomedical (NASDAQ:TLIS – Get Free Report) last issued its quarterly earnings data on Thursday, May 11th. The company reported ($9.90) earnings per share for the quarter, topping the consensus estimate of ($11.10) by $1.20. Talis Biomedical had […]
Preliminary data suggest a chlamydia, gonorrhea and trichomonas (CT/NG/TV) multiplex test is feasible on a molecular point-of-care (POC) test system with time to result in less than 30 minutes